India Equity Analyst - Fundamental & Thematic, Beat the Street

Sudarshan Bhandari

India Equity Analyst - Fundamental & Thematic

Beat the Street

Beat The Street was founded by Nimish Maheshwari and Sudarshan Bhandari, both of whom are Chartered Accountants by Profession, known for their expert analysis in the fields of Business, Sectoral analysis, and Corporate governance.

With a strong social media presence of 45,000+ Subscribers across various platforms, they are considered trusted voices in the industry. Their insights and analysis have been featured in some of India’s most prominent publications, including the Economic Times, Dalal Street Investment Journal, The Morning Context, and The Ken.

Their analysis on Bankrupt & Insolvent companies has been instrumental in saving investors from significant losses. They have a keen eye for identifying red flags and has identified exclusive redflags earlier in Vedanta, Nykaa, Dhani Services, Adani and many more.

Read Business Not Stock Prices

Equity Bottom-Up

Privi Speciality Chemicals / Equity Bottom-Up

<ul>
<li>Privi Speciality Chemicals, <strong>an aroma chemicals manufacturer</strong>, continues expanding its capacities and strengthening its product portfolio to support future growth and deepen its presence in global markets.</li>
<li>Privi operates a structurally <strong>strong business with backward integration</strong>, deep customer relationships, and proprietary processes, making it difficult for competitors to replicate its scale and margins.</li>
<li>Growth visibility remains strong with INR 5,000 crore revenue and INR 1,000 crore EBITDA targets, driven by capex and Givaudan JV, valuation depends on execution and scalability.</li>
</ul>


Privi Speciality Chemicals, an aroma chemicals manufacturer, continues expanding its capacities and strengthening its product portfolio to support future growth and deepen its presence in global markets.
Privi operates a structurally strong business with backward integration, deep customer relationships, and proprietary processes, making it difficult for competitors to replicate its scale and margins.
Growth visibility remains strong with INR 5,000 crore revenue and INR 1,000 crore EBITDA targets, driven by capex and Givaudan JV, valuation depends on execution and scalability.


Privi Speciality Chemicals: A Differentiated Player in Aroma Chemicals

Independent Investment Research, The IDEA!

The IDEA!

Independent Investment Research

The Idea-Driven Equities Analyses company (the IDEA!) is an employee-owned boutique providing independent investment research and financial consultancy services with a clear focus on the Benelux countries. The company was founded in the summer of 2007 by Henk Slotboom and Maarten Verbeek, both with more than 35 years of professional experience in the financial sector. The IDEA! differentiates itself by focusing on adding value through self-initiated in-depth, idea-driven investment research, as well as by bespoke research assignments for institutional investors, hedge funds and private equity. In addition, we provide market intelligence, strategic research and – together with our business partners – consultancy services to businesses. In case you are interested in receiving more information, a sample of our products or an introductory meeting, please send a message to info@theidea.nl.

Aalberts Industries Nv / Equity Bottom-Up

<ul><li>In this edition: • dsm-firmenich | presents new mid-term targets; new EUR 540m share buyback • Aalberts | completes divestment of Broen • Triodos Bank | FY25 results reflect a transition year • Allegro | 4Q25 results broadly in line with consensus; PLN 1.6bn share buyback</li></ul>

In this edition: • dsm-firmenich | presents new mid-term targets; new EUR 540m share buyback • Aalberts | completes divestment of Broen • Triodos Bank | FY25 results reflect a transition year • Allegro | 4Q25 results broadly in line with consensus; PLN 1.6bn share buyback

What's New(s) in Amsterdam - 12 March (dsm-firmenich | Aalberts | Triodos Bank | Allegro)

<ul><li>In this edition: • ASML | strategic redesign to improve the make the company more agile • ING | another clear beat of consensus; ups 2027 ambitions • dsm-firmenich | deal with CVC on AHN business expected to be announced soon • Unilever | sells its Home Care business in Colombia and Ecuador • BAM Group | acquisition strengthens position in Dutch residential market • Dutch politics | fiscally tight budget policy and no to Eurobonds</li></ul>

In this edition: • ASML | strategic redesign to improve the make the company more agile • ING | another clear beat of consensus; ups 2027 ambitions • dsm-firmenich | deal with CVC on AHN business expected to be announced soon • Unilever | sells its Home Care business in Colombia and Ecuador • BAM Group | acquisition strengthens position in Dutch residential market • Dutch politics | fiscally tight budget policy and no to Eurobonds

ASML Holding NV - What's News in Amsterdam

<ul><li>In this edition: • ING | less than expected drop in earnings; new EUR 1.6bn share buyback • dsm-firmenich (‘DSFIR’) | results broadly in line; lowers FY25 guidance • Arcadis | 25Q3 results lagging market consensus (even helped by lower depreciation rate) • General Elections | D66 emerges as big winner; hard to predict new coalition</li></ul>

In this edition: • ING | less than expected drop in earnings; new EUR 1.6bn share buyback • dsm-firmenich (‘DSFIR’) | results broadly in line; lowers FY25 guidance • Arcadis | 25Q3 results lagging market consensus (even helped by lower depreciation rate) • General Elections | D66 emerges as big winner; hard to predict new coalition

What's News in Amsterdam - 30 October (dsm-firmenich | ING | Arcadis | General Elections)

<ul>
<li>EU member states have unanimously backed a Dutch-led proposal to commit tens of billions of euros in future support for the European chip industry, underscoring the sector’s strategic importance.</li>
<li>Outgoing Dutch Economic Affairs Minister Vincent Karremans stressed that continued investment is a “pure necessity” to reduce dependence on the US and China and to safeguard Europe’s economic and geopolitical resilience.</li>
<li>The initiative calls for a follow-up to the 2023 EU Chips Act, which mobilized EUR 43bn for semiconductor R&amp;D, start-ups, and manufacturing capacity.</li>
</ul>


EU member states have unanimously backed a Dutch-led proposal to commit tens of billions of euros in future support for the European chip industry, underscoring the sector’s strategic importance.
Outgoing Dutch Economic Affairs Minister Vincent Karremans stressed that continued investment is a “pure necessity” to reduce dependence on the US and China and to safeguard Europe’s economic and geopolitical resilience.
The initiative calls for a follow-up to the 2023 EU Chips Act, which mobilized EUR 43bn for semiconductor R&amp;D, start-ups, and manufacturing capacity.


Switzerland

DSM-Firmenich AG is an innovator in nutrition, health, and beauty products. The Company reinvents, manufactures, and combines vital nutrients, flavors, and fragrances. DSM-Firmenich serves customers worldwide.

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

DSM-Firmenich (DSFIR NA)

Privi Speciality Chemicals: A Differentiated Player in Aroma Chemicals

Privi Speciality Chemicals, an aroma chemicals manufacturer, strengthens its capacities and product portfolio to deepen global market presence.

Sudarshan Bhandari

What's New(s) in Amsterdam - 12 March (dsm-firmenich | Aalberts | Triodos Bank | Allegro)

In this edition: • dsm-firmenich | presents new mid-term targets; new EUR 540m share buyback • Aalberts | completes divestment of Broen...

The IDEA!

ASML Holding NV - What's News in Amsterdam

In this edition: • ASML | strategic redesign to improve the make the company more agile • ING | another clear beat of consensus; ups 2027...

The IDEA!

What's News in Amsterdam - 30 October (dsm-firmenich | ING | Arcadis | General Elections)

In this edition: • ING | less than expected drop in earnings; new EUR 1.6bn share buyback • dsm-firmenich (‘DSFIR’) | results broadly in line;...

The IDEA!

What's News in Amsterdam

EU member states have unanimously backed a Dutch-led proposal to commit tens of billions of euros in future support for the European chip industry,...

The IDEA!

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)

Privi Speciality Chemicals: A Differentiated Player in Aroma Chemicals

​Privi Speciality Chemicals, an aroma chemicals manufacturer, strengthens its capacities and product portfolio to deepen global market presence.

Sudarshan Bhandari

What's New(s) in Amsterdam - 12 March (dsm-firmenich | Aalberts | Triodos Bank | Allegro)

In this edition: • dsm-firmenich | presents new mid-term targets; new EUR 540m share buyback • Aalberts | completes divestment of Broen...

The IDEA!

ASML Holding NV - What's News in Amsterdam

In this edition: • ASML | strategic redesign to improve the make the company more agile • ING | another clear beat of consensus; ups 2027...

The IDEA!

What's News in Amsterdam - 30 October (dsm-firmenich | ING | Arcadis | General Elections)

In this edition: • ING | less than expected drop in earnings; new EUR 1.6bn share buyback • dsm-firmenich (‘DSFIR’) | results broadly in line;...

The IDEA!

What's News in Amsterdam

EU member states have unanimously backed a Dutch-led proposal to commit tens of billions of euros in future support for the European chip industry,...

The IDEA!

Privi Speciality Chemicals, an aroma chemicals manufacturer, strengthens its capacities and product portfolio to deepen global market presence.